Skip to main content
SpringerLink
Log in

Base the decision to initiate oral corticosteroids in patients with pulmonary sarcoidosis on symptoms and disease severity

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I

References

  1. Coker RK. Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis. Drugs 2007; 67(8): 1139–47

    Article  PubMed  CAS  Google Scholar 

  2. Jindal SK. Practical issues and challenges in the diagnosis and treatment of pulmonary sarcoidosis. Drugs 2007; 67(1): 17–26

    Article  PubMed  CAS  Google Scholar 

  3. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160 (2): 736-55.

    Google Scholar 

  4. The diagnosis, assessment and treatment of diffuse parenchymal lung disease in adults: British Thoracic Society recommendations. Thorax 1999 Apr; 54 Suppl. 1: S1-14

  5. Gibson GJ, Prescott RJ, Muers MF, et al. British Thoracic Society Sarcoidosis study: effects of long-term corticosteroid treatment. Thorax 1996; 51(3): 238–47

    Article  PubMed  CAS  Google Scholar 

  6. Paramothayan S, Jones PW. Corticosteroid therapy in pulmonary sarcoidosis: a systematic review. JAMA 2002; 287(10): 1301–7

    Article  PubMed  CAS  Google Scholar 

  7. Grutters JC, van den Bosch JM. Corticosteroid treatment in sarcoidosis. Eur Respir J 2006; 28(3): 627–36

    Article  PubMed  CAS  Google Scholar 

  8. Milman N. Oral and inhaled corticosteroids in the treatment of pulmonary sarcoidosis: a critical reappraisal. Sarcoidosis Vasc Diffuse Lung Dis 1998; 15(2): 150–7

    PubMed  CAS  Google Scholar 

  9. American College of Rheumatology ad hoc committee on Glucocorticoid-Induced Osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. Arthritis Rheum 2001; 44(7): 1496–503

    Article  Google Scholar 

  10. The management of glucocorticoid-induced osteoporosis in men and women. London: Royal College of Physicians, 2002

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Base the decision to initiate oral corticosteroids in patients with pulmonary sarcoidosis on symptoms and disease severity. Drugs Ther. Perspect 24, 12–14 (2008). https://doi.org/10.2165/00042310-200824030-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824030-00004

Keywords

Search

Navigation